167 related articles for article (PubMed ID: 17682895)
1. Cell therapy for tendon repair in horses: an experimental study.
Crovace A; Lacitignola L; De Siena R; Rossi G; Francioso E
Vet Res Commun; 2007 Aug; 31 Suppl 1():281-3. PubMed ID: 17682895
[No Abstract] [Full Text] [Related]
2. Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon.
Romero A; Barrachina L; Ranera B; Remacha AR; Moreno B; de Blas I; Sanz A; Vázquez FJ; Vitoria A; Junquera C; Zaragoza P; Rodellar C
Vet J; 2017 Jun; 224():76-84. PubMed ID: 28697880
[TBL] [Abstract][Full Text] [Related]
3. The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis.
Caniglia CJ; Schramme MC; Smith RK
Equine Vet J; 2012 Sep; 44(5):587-93. PubMed ID: 22150794
[TBL] [Abstract][Full Text] [Related]
4. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study.
Guest DJ; Smith MR; Allen WR
Equine Vet J; 2008 Mar; 40(2):178-81. PubMed ID: 18267891
[TBL] [Abstract][Full Text] [Related]
5. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.
Guest DJ; Smith MR; Allen WR
Equine Vet J; 2010 Oct; 42(7):636-42. PubMed ID: 20840579
[TBL] [Abstract][Full Text] [Related]
6. Tendon injuries and their treatment in the horse.
McCullagh KG; Goodship AE; Silver IA
Vet Rec; 1979 Jul; 105(3):54-7. PubMed ID: 400209
[No Abstract] [Full Text] [Related]
7. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.
Pacini S; Spinabella S; Trombi L; Fazzi R; Galimberti S; Dini F; Carlucci F; Petrini M
Tissue Eng; 2007 Dec; 13(12):2949-55. PubMed ID: 17919069
[TBL] [Abstract][Full Text] [Related]
8. Cell therapy for tendinitis, experimental and clinical report.
Lacitignola L; Crovace A; Rossi G; Francioso E
Vet Res Commun; 2008 Sep; 32 Suppl 1():S33-8. PubMed ID: 18686004
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis.
Dahlgren LA; van der Meulen MC; Bertram JE; Starrak GS; Nixon AJ
J Orthop Res; 2002 Sep; 20(5):910-9. PubMed ID: 12382953
[TBL] [Abstract][Full Text] [Related]
10. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.
Smith RK; Korda M; Blunn GW; Goodship AE
Equine Vet J; 2003 Jan; 35(1):99-102. PubMed ID: 12553472
[No Abstract] [Full Text] [Related]
11. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.
Lange-Consiglio A; Tassan S; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
Cytotherapy; 2013 Aug; 15(8):1011-20. PubMed ID: 23602577
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.
Smith RK; Werling NJ; Dakin SG; Alam R; Goodship AE; Dudhia J
PLoS One; 2013; 8(9):e75697. PubMed ID: 24086616
[TBL] [Abstract][Full Text] [Related]
13. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.
Sole A; Spriet M; Padgett KA; Vaughan B; Galuppo LD; Borjesson DL; Wisner ER; Vidal MA
Equine Vet J; 2013 Nov; 45(6):726-31. PubMed ID: 23574488
[TBL] [Abstract][Full Text] [Related]
14. Stem cells in veterinary medicine--attempts at regenerating equine tendon after injury.
Richardson LE; Dudhia J; Clegg PD; Smith R
Trends Biotechnol; 2007 Sep; 25(9):409-16. PubMed ID: 17692415
[TBL] [Abstract][Full Text] [Related]
15. Making progress in the what, when and where of regenerative medicine for our equine patients.
Fortier LA
Equine Vet J; 2012 Sep; 44(5):511-2. PubMed ID: 22888773
[No Abstract] [Full Text] [Related]
16. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.
Godwin EE; Young NJ; Dudhia J; Beamish IC; Smith RK
Equine Vet J; 2012 Jan; 44(1):25-32. PubMed ID: 21615465
[TBL] [Abstract][Full Text] [Related]
17. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: A placebo-controlled experimental study.
Bosch G; van Schie HT; de Groot MW; Cadby JA; van de Lest CH; Barneveld A; van Weeren PR
J Orthop Res; 2010 Feb; 28(2):211-7. PubMed ID: 19714688
[TBL] [Abstract][Full Text] [Related]
18. The nature of tendon damage and its repair.
Fackelman GE
Equine Vet J; 1973 Oct; 5(4):141-9. PubMed ID: 4766687
[No Abstract] [Full Text] [Related]
19. Effects of sodium hyaluronate on tendon healing and adhesion formation in horses.
Gaughan EM; Nixon AJ; Krook LP; Yeager AE; Mann KA; Mohammed H; Bartel DL
Am J Vet Res; 1991 May; 52(5):764-73. PubMed ID: 1854104
[TBL] [Abstract][Full Text] [Related]
20. Distribution of injected technetium(99m)-labeled mesenchymal stem cells in horses with naturally occurring tendinopathy.
Becerra P; Valdés Vázquez MA; Dudhia J; Fiske-Jackson AR; Neves F; Hartman NG; Smith RK
J Orthop Res; 2013 Jul; 31(7):1096-102. PubMed ID: 23508674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
